Study to Evaluate Ospemifene in Patients With Moderate to Severe Vaginal Dryness Due to Menopause

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
The objective of this study is to evaluate the efficacy and safety of ospemifene 60 mg once daily (QD) compared with placebo in treatment of vulvo-vaginal atrophy (VVA) due to menopause in women with moderate to severe vaginal dryness as the most bothersome symptom (MBS) of VVA.
Epistemonikos ID: 80e56b0e20acba095f90c95da471249df5cc417a
First added on: May 12, 2024